BMRN - BIOMARIN PHARMACEUTICAL INC
60.43
1.900 3.144%
Share volume: 2,042,825
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$58.53
1.90
0.03%
Summary score
26%
Profitability
20%
Dept financing
9%
Liquidity
69%
Performance
27%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0.62%
Return on assets
-0.8%
Return on sales
-10.13%
Return on invested capital
1.07%
Total debt ratio
34.7%
Debt ratio change over timeo
0%
Current Ratio
3.38%
Quick Ratio
2.47%
Cash Position Ratio
0.87%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
5.36%
Return on assets
-0.39%
Return on sales
-5.37%
Return on invested capital
8.6%
Total debt ratio
34.49%
Debt ratio change over timeo
0%
Current Ratio
2.78%
Quick Ratio
1.95%
Cash Position Ratio
0.95%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
19.36%
Return on assets
-0.92%
Return on sales
-11.93%
Return on invested capital
30.6%
Total debt ratio
34.17%
Debt ratio change over time
0%
Current Ratio
3.2%
Quick Ratio
2.38%
Cash Position Ratio
1.76%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BMRN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0.62% | 18.71% | 4.67% | -3.65% |
| Return on assets | -0.8% | 3.4% | 3.32% | 3.5% |
| Return on sales | -10.13% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | 1.07% | 5.38% | 4.17% | 4.99% |
| Profitability | 6% | 94% | 70% | 73% |
| Total debt ratio | 34.7% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 9% | 20% | 20% | 50% |
| Current Ratio | 2.78% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 1.95% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 0.95% | 0.21% | 0.6% | 1.41% |
| Liquididy | 75% | 30% | 41% | 45% |
| Short-term ratios | BMRN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 5.36% | 41.05% | 6.87% | -16.17% |
| Return on assets | -0.39% | 3.67% | 3.13% | 2.71% |
| Return on sales | -5.37% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | 8.6% | 9.43% | 5.58% | 6.54% |
| Profitability | 26% | 97% | 61% | 61% |
| Total debt ratio | 34.49% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 9% | 23% | 40% | 25% |
| Current Ratio | 2.78% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 1.95% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 0.95% | 0.21% | 0.6% | 1.41% |
| Liquididy | 67% | 27% | 36% | 68% |